These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 19428588)
1. Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins. Pozzi E; Basavecchia V; Zanotto C; Pacchioni S; Morghen Cde G; Radaelli A J Virol Methods; 2009 Jun; 158(1-2):184-9. PubMed ID: 19428588 [TBL] [Abstract][Full Text] [Related]
2. Development of an adenoviral vaccine against E6 and E7 oncoproteins to prevent growth of human papillomavirus-positive cancer. Lee DW; Anderson ME; Wu S; Lee JH Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1316-23. PubMed ID: 19075129 [TBL] [Abstract][Full Text] [Related]
3. A DNA vaccine encoding a codon-optimized human papillomavirus type 16 E6 gene enhances CTL response and anti-tumor activity. Lin CT; Tsai YC; He L; Calizo R; Chou HH; Chang TC; Soong YK; Hung CF; Lai CH J Biomed Sci; 2006 Jul; 13(4):481-8. PubMed ID: 16649071 [TBL] [Abstract][Full Text] [Related]
4. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029 [TBL] [Abstract][Full Text] [Related]
5. Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X. Illiano E; Bissa M; Paolini F; Zanotto C; De Giuli Morghen C; Franconi R; Radaelli A; Venuti A Virus Res; 2016 Oct; 225():82-90. PubMed ID: 27664839 [TBL] [Abstract][Full Text] [Related]
6. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation. Seo SH; Jin HT; Park SH; Youn JI; Sung YC Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174 [TBL] [Abstract][Full Text] [Related]
7. Immunization strategy against cervical cancer involving an alphavirus vector expressing high levels of a stable fusion protein of human papillomavirus 16 E6 and E7. Daemen T; Regts J; Holtrop M; Wilschut J Gene Ther; 2002 Jan; 9(2):85-94. PubMed ID: 11857066 [TBL] [Abstract][Full Text] [Related]
8. A prime/boost strategy by DNA/fowlpox recombinants expressing a mutant E7 protein for the immunotherapy of HPV-associated cancers. Radaelli A; De Giuli Morghen C; Zanotto C; Pacchioni S; Bissa M; Franconi R; Massa S; Paolini F; Muller A; Venuti A Virus Res; 2012 Dec; 170(1-2):44-52. PubMed ID: 22951311 [TBL] [Abstract][Full Text] [Related]
9. DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins. Wlazlo AP; Deng H; Giles-Davis W; Ertl HC Cancer Gene Ther; 2004 Jun; 11(6):457-64. PubMed ID: 15118761 [TBL] [Abstract][Full Text] [Related]
10. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. Rampias T; Sasaki C; Weinberger P; Psyrri A J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448 [TBL] [Abstract][Full Text] [Related]
12. Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein. Zanotto C; Pozzi E; Pacchioni S; Bissa M; De Giuli Morghen C; Radaelli A J Transl Med; 2011 Nov; 9():190. PubMed ID: 22053827 [TBL] [Abstract][Full Text] [Related]
13. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells. Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212 [TBL] [Abstract][Full Text] [Related]
14. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Toussaint-Smith E; Donner DB; Roman A Oncogene; 2004 Apr; 23(17):2988-95. PubMed ID: 14968115 [TBL] [Abstract][Full Text] [Related]
15. Characterization of HPV-16 E6 DNA vaccines employing intracellular targeting and intercellular spreading strategies. Peng S; Trimble C; Ji H; He L; Tsai YC; Macaes B; Hung CF; Wu TC J Biomed Sci; 2005 Oct; 12(5):689-700. PubMed ID: 16200349 [TBL] [Abstract][Full Text] [Related]
16. Superior therapeutic efficacy of alphavirus-mediated immunization against human papilloma virus type 16 antigens in a murine tumour model: effects of the route of immunization. Daemen T; Riezebos-Brilman A; Regts J; Dontje B; van der Zee A; Wilschut J Antivir Ther; 2004 Oct; 9(5):733-42. PubMed ID: 15535411 [TBL] [Abstract][Full Text] [Related]
17. HPV-16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Liu X; Han S; Baluda MA; Park NH Oncogene; 1997 May; 14(19):2347-53. PubMed ID: 9178911 [TBL] [Abstract][Full Text] [Related]
18. A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers. Bissa M; Illiano E; Pacchioni S; Paolini F; Zanotto C; De Giuli Morghen C; Massa S; Franconi R; Radaelli A; Venuti A J Transl Med; 2015 Mar; 13():80. PubMed ID: 25763880 [TBL] [Abstract][Full Text] [Related]
19. Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits. Radaelli A; Pozzi E; Pacchioni S; Zanotto C; Morghen Cde G J Transl Med; 2010 Apr; 8():40. PubMed ID: 20409340 [TBL] [Abstract][Full Text] [Related]
20. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Duensing S; Münger K Cancer Res; 2002 Dec; 62(23):7075-82. PubMed ID: 12460929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]